New sepsis definition (Sepsis-3) and community-acquired pneumonia mortality: A validation and clinical decision-making study

dc.contributor.authorRanzani, Otavio T.
dc.contributor.authorPrina, Elena
dc.contributor.authorMenéndez, Rosario
dc.contributor.authorCeccato, Adrian
dc.contributor.authorCillóniz, Catia
dc.contributor.authorMéndez, Raúl
dc.contributor.authorGabarrús, Albert
dc.contributor.authorBarbeta, Enric
dc.contributor.authorBassi, Gianluigi Li
dc.contributor.authorFerrer, Miquel
dc.contributor.authorTorres Martí, Antoni
dc.date.accessioned2019-09-04T15:00:18Z
dc.date.available2019-09-04T15:00:18Z
dc.date.issued2017-11-15
dc.date.updated2019-09-04T15:00:18Z
dc.description.abstractRATIONALE: The Sepsis-3 Task Force updated the clinical criteria for sepsis, excluding the need for systemic inflammatory response syndrome (SIRS) criteria. The clinical implications of the proposed flowchart including the quick Sequential (Sepsis-related) Organ Failure Assessment (qSOFA) and SOFA scores are unknown. OBJECTIVES: To perform a clinical decision-making analysis of Sepsis-3 in patients with community-acquired pneumonia. METHODS: This was a cohort study including adult patients with community-acquired pneumonia from two Spanish university hospitals. SIRS, qSOFA, the Confusion, Respiratory Rate and Blood Pressure (CRB) score, modified SOFA (mSOFA), the Confusion, Urea, Respiratory Rate, Blood Pressure and Age (CURB-65) score, and Pneumonia Severity Index (PSI) were calculated with data from the emergency department. We used decision-curve analysis to evaluate the clinical usefulness of each score and the primary outcome was in-hospital mortality. MEASUREMENTS AND MAIN RESULTS: Of 6,874 patients, 442 (6.4%) died in-hospital. SIRS presented the worst discrimination, followed by qSOFA, CRB, mSOFA, CURB-65, and PSI. Overall, overestimation of in-hospital mortality and miscalibration was more evident for qSOFA and mSOFA. SIRS had lower net benefit than qSOFA and CRB, significantly increasing the risk of over-treatment and being comparable with the 'treat-all' strategy. PSI had higher net benefit than mSOFA and CURB-65 for mortality, whereas mSOFA seemed more applicable when considering mortality/intensive care unit admission. Sepsis-3 flowchart resulted in better identification of patients at high risk of mortality. CONCLUSIONS: qSOFA and CRB outperformed SIRS and presented better clinical usefulness as prompt tools for patients with community-acquired pneumonia in the emergency department. Among the tools for a comprehensive patient assessment, PSI had the best decision-aid tool profile.
dc.format.extent60 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec675108
dc.identifier.idimarina2987705
dc.identifier.issn1073-449X
dc.identifier.pmid28613918
dc.identifier.urihttps://hdl.handle.net/2445/139299
dc.language.isoeng
dc.publisherAmerican Thoracic Society
dc.relation.isformatofVersió postprint del document publicat a: https://doi.org/10.1164/rccm.201611-2262OC
dc.relation.ispartofAmerican Journal of Respiratory and Critical Care Medicine, 2017, vol. 196, num. 10, p. 1287-1297
dc.relation.urihttps://doi.org/10.1164/rccm.201611-2262OC
dc.rights(c) American Thoracic Society, 2017
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.sourceArticles publicats en revistes (Medicina)
dc.subject.classificationPneumònia adquirida a la comunitat
dc.subject.classificationMortalitat
dc.subject.classificationSepticèmia
dc.subject.otherCommunity-acquired pneumonia
dc.subject.otherMortality
dc.subject.otherSepticemia
dc.titleNew sepsis definition (Sepsis-3) and community-acquired pneumonia mortality: A validation and clinical decision-making study
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/acceptedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
675108.pdf
Mida:
9.35 MB
Format:
Adobe Portable Document Format